Scientists discover why promising cancer drugs keep failing in patients
New research reveals why BET inhibitor cancer drugs work in labs but fail in patients, pointing to better treatment strategies.
48 articles in this topic
New research reveals why BET inhibitor cancer drugs work in labs but fail in patients, pointing to better treatment strategies.
Breakthrough non-invasive device offers new hope for pancreatic cancer patients with at-home treatment option.
Bemnifosbuvir blocks hepatitis E replication in lab tests, offering hope for treating a virus that kills 70,000 people annually.
New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.
New study shows PCSK9 inhibitor prevents cardiovascular events in high-risk diabetes patients without existing heart disease.
New study finds 27% of patients with treatment-resistant hypertension have elevated cortisol levels that could explain medication failures.
New research reveals colorectal cancer has distinct microbial communities that could improve diagnosis and personalized treatment approaches.
Updated guidelines recommend cholesterol screening in childhood and tracking genetic factors like lipoprotein(a) for personalized prevention.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
Scientists discover nerve fibers create a self-sustaining loop that accelerates pancreatic cancer development before tumors even form.
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.